UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 84 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$149,79610,5120.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$63,067,42234.64%
5AM Venture Management, LLC 4,408,379$62,819,40114.05%
StepStone Group LP 761,277$10,848,1972.20%
Baker Brothers Advisors 4,865,819$69,337,9210.89%
TCG Crossover Management, LLC 584,955$8,335,6090.87%
Nan Fung Group Holdings Ltd 49,082$699,4190.75%
Redmile Group, LLC 560,971$7,993,8370.48%
Corton Capital Inc. 54,973$783,3650.41%
CORNERCAP INVESTMENT COUNSEL INC 13,014$185,4500.03%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,496,2500.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders